Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01575951 · ClinicalTrials.gov registry record · NA
Pilot Study: Dynamic Contrast-enhanced Magnetic Resonance Imaging(DCE-MRI)for Assessing Tumor Vascularity and Permeability in Soft Tissue Sarcoma Treated With Preoperative Radiotherapy Followed by Surgical Resection
A NA study, sponsored by University of Utah.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT01575951 is a NA study that has completed, run by University of Utah. The registered enrollment target is 16 participants.
The verdict
NCT01575951, a NA study, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
This is a pilot study to determine the diagnostic value of dynamic contrast enhancing MRI (DCE-MRI) in soft tissue sarcoma for assessment of tumor radiographic changes in vascular permeability and microvessel density before and after preoperative radiotherapy.
Interventions
- RADIATION MRI-DCE
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2010-02 |
| Est. Completion | 2014-12-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01575951
The ClinicalTrials.gov registry entry for NCT01575951 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MRI-DCE is the first listed.
NCT01575951 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01575951 about?
NCT01575951 is a clinical study titled "Pilot Study: Dynamic Contrast-enhanced Magnetic Resonance Imaging(DCE-MRI)for Assessing Tumor Vascularity and Permeability in Soft Tissue Sarcoma Treated With Preoperative Radiotherapy Followed by Surgical Resection". This is a pilot study to determine the diagnostic value of dynamic contrast enhancing MRI (DCE-MRI) in soft tissue sarcoma for assessment of tumor radiographic changes in vascular permeability and microvessel density before and after preoperative radiotherapy.
What is the current status of trial NCT01575951?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2010-02. Estimated completion is 2014-12-05.
What interventions are being tested in trial NCT01575951?
The interventions under investigation include: MRI-DCE (RADIATION).
Who is sponsoring clinical trial NCT01575951?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.